|
lunes
|
martes
|
miércoles
|
jueves
|
viernes
|
sábado
|
domingo
|
|---|---|---|---|---|---|---|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
1 evento,
—
Chronic inflammation is considered one of the main drivers of cancer progression and cytokines are key regulators of this inflammation. Recent data from our group support that cytokine Oncostatin M (OSM) acts as a key player in the interactions in the breast tumour microenvironment, where OSM activates an intriguing pro-tumoral signalling in cancer-associated fibroblasts (CAFs) […] |
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
1 evento,
—
Programa TREBEA: Desarrollo, implementación y resultados preliminares El programa piloto TREBEA, es un novedoso tratamiento integral para pacientes con Trastorno Límite de Personalidad que ha sido desarrollado con un enfoque interdisciplinar y transcultural en la Red de Salud Mental de Gipuzkoa y está siendo evaluado. Los pacientes son derivados desde 13 centros de salud mental de […] |
0 eventos,
|
0 eventos,
|
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|
0 eventos,
|